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  A  series  of  some  new  (E)-2-(arylbenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazides 
4(a-j) have  been conveniently synthesized  by intermolecular  oxidative  cyclization of  (E)-2-
(arylbenzylidene)-2-[(4-methoxyphenyl)amino]acetohydrazides  promoted  by  iodobenzene 
diacetate as an oxidant. The structures of the synthesized compounds have been confirmed by 
1H NMR, IR, MS and elemental analysis. All the synthesized compounds were tested for their 
inhibitory action against clinically isolated strains i.e., Bacillus subtilis, Staphylococcus aureus, 
Xanthomonas campestris, Escherichia coli and  Fusarium oxysporum. Compounds 4f (21-28 
mm,  73.8  %),  4i  (20-24  mm,  72.4  %)  and  4j  (21-27  mm,  71.6  %)  demonstrated  good 
antimicrobial activity against all the tested bacterial and fungal strains. 
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1. Introduction     
     In the past decades, the problem of multidrug resistant micro-organism has reached on alarming 
level around the world, and the synthesis of new anti-infective compounds has become an urgent 
need for the treatment of microbial infections. There are various problems arising with the use of 
antimicrobials  such  as  local  tissue  irritation,  interference  with  wound  healing  process, 
hypersensitivity  reactions,  system  toxicity,  narrow  antimicrobial  spectrum,  and  emergence  of   168
resistance.
1,2 Therefore, the increasing clinical importance of drug resistant microbial pathogens has 
additional urgency in microbiological and antifungal research. Compounds containing heterocyclic 
ring systems continue to attract considerable interest due to the wide range of biological activities 
they  possess.
3  Among  them  five  membered  rings  gained  importace  because  of  their  versatile 
biological properties.
3 In particular, compounds bearing 1,3,4-oxadiazoles nucleus are known to have 
unique  angioedema  and  anti-inflammatory  activities.
4  Substituted  oxadiazoles  molecules  possess 
other  interesting  properties  such  as  analgesic
5,  antimicrobial
6,  antiviral
7,  anticonvulsant
8, 
antihypertensive
9, anti-proliferative
10, enzyme Inhibitors
11, 5-HT-receptor antagonists
12 and inhibitors 
of muscle glycogen phosphorylase
13. 
      Literature reveals that docking study of N-(hetarylmethyl)-aniline derivatives showed anticancer 
activity
14 and N-aryl-N-benzylamines were synthesized and evaluated for their antifungal activity, 
which was compared with their homoallylamine analogues that possessed an allyl group in the carbon 
next  to  the  nitrogen  atom.  Results  indicated  that  the  absence  of  the  allyl  group  caused  an 
enhancement of the antifungal activity which could be correlated with the flexibility of the alkyl 
chain between both aromatic groups.
15 This led to the preparation of N-substituted amines bearing a 
hetaryl fragments (N-(hetarylmethyl)-anilines). 
2. Results and discussion 
2.1. Chemistry 
     The new compounds were prepared by using the synthetic strategy described in Scheme 1. The 2-
(4-methoxyphenylamino)acetohydrazide  2  was  synthesized  by  the  reaction  of  ethyl-(4-
methoxyphenyl)glycinate 1 with hydrazine hydrate in ethanol as per the reported procedure
15.  
     The  (E)-2-(arylbenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide  (3a-j)  was  synthesized 
by  the  reaction  of    2-(4-methoxyphenylamino)acetohydrazide  2.  It  was  refluxed  with  different 
substituted aldehydes in ethanolic solution for about 2 h. A series of new 2,5-disubstituted-1,3,4-
oxadiazoles (Table 1) have been accomplished in excellent yields by the oxidation of  3a-j of various 
aryl aldehydes with one equivalent of iodobenzenediacetate (IBD) in dichloromethane. Compounds 
3a-j and 4a-j were synthesized based on the reported procedure.
16, 17 
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a) Hydrazine hydrate, ethanol, reflux 3 h, b) Aryl aldehydes, ethanol, reflux 2 h, c) IBD, DCM, reflux 2 h. 
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     The IR spectra of the compound 3a exhibited characteristic bands at absorption bands at 1631 cm
-1 
and 3150 cm
-1 due to for carbonyl and NH group, respectively. The 
1H NMR spectra of 3a showed 
two singlet due at N=CH and NH at δ 8.58 and δ 9.34, respectively.  The structure of all compounds 
4a-j  confirmed  by  their  spectral  (IR,  LCMS,  and 
1H  NMR)  and  elemental  analysis.  The 
characterization of products 4a-j was based upon a careful comparison of their IR and 
1H NMR 
spectra with those of 3a-j. IR spectra of 4a were found to be transparent in the region of NH stretch 
and CO stretch. In 
1H NMR spectra of 4a the disappearance of their singlet due to N=CH around δ 
8.4-8.6 and NH proton around δ 9.3-9.5, thus confirming the oxidation of 3a-j into 4a-j. The mass 
spectra of 4a showed molecular  ion peak at m/z 342,  which  is  in agreement with the molecular 
formula C18H19N3O4.  
Table 1. Chemical structure and physical data of 2,5-disubstituted-1,3,4-oxadiazoles (4a-j) 
Comp.  Ar  Structure  Yield, %  mp (°C) 
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3a-j (1 eq), IBD (1 eq), methanol, reflux. 
2.2. Antimicrobial activity 
      Compounds (4a-j) were tested in vitro for their antibacterial activity against two gram positive 
and  two  gram  negative  bacterial  strains.  Commercial  antibiotics  such  as  bacteriomycin  and 
gentamycin  were  used  as  standard  drugs.  The  results  were  compared  with  standard  drugs  and 
depicted in Table 2. Compound 4f was found to be more potent against gram positive and gram 
negative bacterial strains with the zone of inhibition respectively 21-28 mm. Compounds 4i and 4j 
exhibited 20-24 mm and 21-27 mm, respectively against all the bacterial strains. Compounds 4a, 4b, 
4d, 4e and 4g were showed moderate antibacterial activity and compound 4d was found to be slightly 
active than 4a, 4e, 4b  and 4g. A compound 4h was weakly active against tested bacterial strains. 
      The in vitro antifungal activity of the new oxadiazole derivatives (4a-j) was studied against the 
fungal strain, Fusarium oxysporum. Nystatin was used as a standard drug and the results are given in 
Table 2. Compounds 4f, 4i and 4j showed 73.8 %, 72.4 % and 71.6 % inhibition, respectively when 
compared to standard drug (100 %). Compounds 4d (69.0 %), 4e (63.1 %), 4b (56.4 %), 4g (52.0 %) 
and 4a (53.8 %) exhibited moderate antifungal activity against tested fungal strain. On the other hand, 
the lowest antifungal effect was detected for compounds 4h (51.9 %) and 4c (50.2 %) against tested 
fungal strain. In the present study different groups attached to aryl ring as substituent linkage to 1,3,4-
oxadiazole ring. The close survey of antimicrobial efficacy indicated that the inhibition values of all 
the compounds exhibited a different range of activity against the tested strains. The biological results 
for compounds (4a-j) showed that the substitution pattern on phenyl ring appears to be vital for broad 
spectrum activity.  B. N. Prasanna Kumar et al. / Current Chemistry Letters 2 (2013) 
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Table 2. In vitro antibacterial and antifungal activities of the synthesized compounds 
Compound  Zone of inhibition in diameter (mm)  % Inhibition 
B. subtilis  S. aureus  X. campestris  E. coli  F. oxysporum 
4a  18  18  17  16  53.8 
4b  18  19  19  22  56.4 
4c  12  13  12  13  50.2 
4d  21  20  19  23  69.0 
4e  19  19  20  21  63.1 
4f  25  23  21  28  73.8 
4g  16  18  17  16  52.0 
4h  14  15  14  15  51.9 
4i  22  21  20  24  72.4 
4j  23  22  21  27  71.6 
Bacteriomycin  -  -  34  -  - 
Gentamycin  35  30  -  35  - 
Nystatin  -  -  -  -  100 
Antibacterial activity was expressed in Zone of inhibition (mm), Antifungal activity was expressed in % inhibition (mm) 
3. Conclusions 
     In conclusion, a series of new 2,5-disubstituted-1,3,4-oxadiazoles (4a-j) were synthesized in good 
yield,  characterized  by  different  spectral  studies  and  their  antimicrobial  activities  have  been 
evaluated. Compounds 4f, 4i and 4j demonstrated good inhibition against microbial strains tested. 
The substituent on phenyl ring is responsible for the antimicrobial activity of these classes of agents. 
On the basis of their activity, these derivatives were identified as viable leads for further studies. 
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4. Experimental  
4.1. Materials and Methods 
     All  solvents  and  reagents  were  purchased  from  Merck  Chemicals,  India.  Melting  point  was 
determined by VMP III apparatus. An elemental analysis was recorded on Vario MICRO superuser 
V1.3.2  Elementar.  The  IR  spectra  were  recorded  using  KBr  discs  on  IR  Jasco  4100  infrared 
spectrophotometer. 
1H  NMR  spectra  was  recorded  using  d6-DMSO  as  solvent  on  Bruker  DRX-500 
spectrometer at 400 MHz. The mass spectrum was recorded using the instrument LC-MSD-Trap-XCT. 
4.2. Synthesis of 2-(4-methoxyphenylamino)acetohydrazide (2) 
      A solution of ethyl-(4-methoxyphenyl)glycinate 1 (10 gm, 0.048 mmol) in ethanol was taken, 
hydrazine hydrate (5 mL) was added, and then reaction mixture refluxed for 3 h. The reaction mixture 
was cooled and the solid formed was filtered and washed with chilled ethanol. Yield: 78 %. mp 116-
118 
oC. 
1H NMR (DMSO-d6, 400 MHz) δ: 4.51 (s, 2H, NH2), 4.60 (s, 2H, -CH2), 7.10 (dd, 2H, Ar-
H), 7.79 (dd, 2H, Ar-H). 
4.3.  General  procedure  for  the  synthesis  of  (E)-2-(arylbenzylidene)-2-((4-
methoxyphenyl)amino)acetohydrazides (3a-j) 
     Compound 2 was refluxed with different aryl aldehydes in ethanolic solution (10 mL) for about 2 
h. Reaction completion was confirmed by the thin layer chromatography (TLC). The reaction mass 
was cooled to 5 to 10 
oC for 1 h. The reaction mass was filtered and washed with ethanol. The 
obtained solid was dried to get the pure product.   172
4.3.1. (E)-N-(2,4-Dimethoxybenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3a)  
      The  compound  3a  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  2,4-
dimethoxybenzaldehyde (0.85 gm, 0.005 mmol) using the general procedure described for 3(a-j). 
Yield 90 %. mp 151-153 
oC. IR (KBr, cm
−1): 3300 and 3150 (N-H), 3073 (C-H), 1681 (C=N), 1631 
(C=O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 3H, -OCH3), 3.88 (s, 6H, -OCH3), 4.60 (d, 2H, -
CH2), 6.35 (s, NH), 7.03 (d, 2H, Ar-H), 7.44-7.48 (m, 3H, Ar-H), 7.82 (d, 2H, Ar-H),  8.58 (s, 
N=CH), 9.34 (s, NH). 
4.3.2. (E)-N-(2,3-Dimethoxybenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3b) 
       The  compound  3b  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  2,3-
dimethoxybenzaldehyde (0.85 gm, 0.005 mmol) using the general procedure described for 3(a-j). 
Yield 84 %. mp 155-157 
oC. IR (KBr, cm
−1): 3310 and 3155 (N-H), 3070 (C-H), 1680 (C=N), 1634 
(C=O),  
1H NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 6H, -OCH3), 3.88 (s, 3H, -OCH3), 4.59 (d, 2H, -
CH2), 6.37 (s, NH), 7.16-7.20 (m,  4H, Ar-H), 7.88-7.90 (m, 3H, Ar-H), 8.57 (s, N=CH), 9.28 (s, NH). 
4.3.3. (E)-N-(3-hydroxybenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3c) 
       The  compound  3c  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  3-
hydroxybenzaldehyde (0.63 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 
88 %. mp 160-162 
oC. IR (KBr, cm
−1): 3314 and 3171 (N-H), 3066 (C-H), 1676 (C=N), 1630 (C=O).  
1H NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 3H, -OCH3), 4.58 (d, 2H, -CH2), 5.22 (s, 1H, OH), 6.38 (s, 
NH), 7.01 (dd,  2H, Ar-H), 7.23-7.36 (m, 4H, Ar-H), 7.89 (t, 2H, Ar-H),  8.50 (s, N=CH), 9.20 (s, NH). 
4.3.4. (E)-N-(3-methoxybenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3d) 
        The  compound  3d  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  3-
methoxybenzaldehyde (0.70 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 
90 %. mp 171-173 
oC. IR (KBr, cm
−1): 3318 and 3170 (N-H), 3069 (C-H), 1670 (C=N), 1630 (C=O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 3H, -OCH3), 3.88 (s, 3H, -OCH3), 4.59 (d, 2H, -CH2), 
6.37 (s, NH), 7.04-7.10 (d, 4H, Ar-H), 7.59 (s, 1H, Ar-H), 7.66-7.75 (m, 3H, Ar-H). 8.51 (s, N=CH), 
9.32 (s, NH). 
4.3.5. (E)-N-(2-chloro-6-fluorobenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3e) 
      The  compound 3e was obtained  by the reaction of  2  (1.0 gm,  0.005 mmol)  and 2-chloro-6-
fluorobenzaldehyde (0.81 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 84 
%. mp 149-151 
oC. IR (KBr, cm
−1): 3306 and 3170 (N-H), 3060 (C-H), 1672 (C=N), 1636 (C=O). 
1H 
NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 3H, -OCH3), 4.59 (d, 2H, -CH2), 6.38 (s, NH), 7.08 (dd, 2H, 
Ar-H), 7.31-7.34 (t, 1H, Ar-H), 7.45-7.48 (m, 4H, Ar-H), 8.48 (s, N=CH), 9.29 (s, NH). 
4.3.6. (E)-N-(2,4-dichlorobenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3f) 
     The  compound  3f  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  2,4-
dichlorobenzaldehyde (0.90 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 
90 %. mp 164-166 
oC. IR (KBr, cm
−1): 3308 and 3166 (N-H), 3069 (C-H), 1676 (C=N), 1630 (C=O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 6H, -OCH3), 4.60 (d, 2H, -CH2), 6.37 (s, NH), 6.99-7.10 
(m, 8.26 Hz, 3H, Ar-H), 7.80-7.93 (m, 4H, Ar-H), 8.44 (s, N=CH), 9.33 (s, NH). 
4.3.7. (E)-2-((4-methoxyphenyl)amino)-N-(4-nitrobenzylidene)acetohydrazide (3g) 
     The  compound  3g  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  4-
nitrobenzaldehyde (0.77 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 89 
%. mp 180-182 
oC. IR (KBr, cm
−1): 3310 and 3170 (N-H), 3074 (C-H), 1680 (C=N), 1635 (C=O). 
1H B. N. Prasanna Kumar et al. / Current Chemistry Letters 2 (2013) 
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NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 3H, -OCH3), 4.59 (d, 2H, -CH2), 6.37 (s, NH), 7.05 (dd, 2H, 
Ar-H), 7.66 (dd, 2H, Ar-H), 8.04-8.13 (m, 4H, Ar-H). 8.43 (s, N=CH), 9.31 (s, NH). 
4.3.8. (E)-N-(4-propylbenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazide (3h) 
      The  compound  3h  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  4-
propylbenzaldehyde (0.76 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 
90 %, mp 179-181 
oC. IR (KBr, cm
−1): 3300 and 3165 (N-H), 3070 (C-H), 1678 (C=N), 1634 (C=O). 
1H NMR (DMSO-d6, 400 MHz) δ: 0.90 (t, 3H, CH3), 1.54-1.62 (m, 2H, CH2), 2.48-2.50 (t, 2H, CH2), 
3.87 (s, 3H, -OCH3), 4.59 (d, 2H, -CH2), 6.37 (s, NH), 7.08 (dd,  2H, Ar-H), 7.77-7.52 (m, 4H, Ar-
H), 7.90 (d, 2H, Ar-H). 8.41 (s, N=CH), 9.36 (s, NH).   
4.3.9. (E)-2-[(4-methoxyphenyl)amino]-N-((3-methylbenzylidene)acetohydrazide (3i) 
       The  compound  3i  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  3-
methylbenzaldehyde (0.62 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 
85 %. mp 158-160 
oC. IR (KBr, cm
−1): 3310 and 3168 (N-H), 3075 (C-H), 1671 (C=N), 1632 (C=O). 
1H 
NMR (DMSO-d6, 400 MHz) δ: 2.20 (s, 3H, -CH3), 3.88 (s, 3H, -OCH3), 4.60 (d, 2H, -CH2), 6.36 (s, NH), 
7.06 (dd, 2H, Ar-H), 7.77-7.84 (m, 5H, Ar-H), 8.10-8.15 (m, 1H, Ar-H). 8.41 (s, N=CH), 9.30 (s, NH). 
4.3.10. (E)-N-(4-bromobenzylidene)-2-[(4-methoxyphenyl)amino]acetohydrazide (3j) 
       The  compound  3j  was  obtained  by  the  reaction  of  2  (1.0  gm,  0.005  mmol)  and  4-
bromolbenzaldehyde (0.95 gm, 0.005 mmol) using the general procedure described for 3(a-j). Yield 
88 %. mp 177-179 
oC. IR (KBr, cm
−1): 3308 and 3168 (N-H), 3068 (C-H), 1672 (C=N), 1638 (C=O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 3H, -OCH3), 4.60 (d, 2H, -CH2), 6.36 (s, NH), 7.06-7.18 
(m, 4H, Ar-H), 7.46 (d, 2H, Ar-H), 8.1 (d, 2H, Ar-H), 8.47 (s, N=CH), 9.32 (s, NH). 
4.4. General procedure for the synthesis of 2,5-disubstituted-1,3,4-oxadiazoles (4a-j) 
       (E)-2-(arylbenzylidene)-2-((4-methoxyphenyl)amino)acetohydrazides  (3a-j)  was  dissolved  in 
dichloromethane and IBD  were added to it. The contents were stirred for 2 h and the progress of the 
reaction was monitored by TLC. The solvent was removed and the residue was taken in petroleum 
ether and stirred for 30 min. The solid thus obtained was filtered, washed with petroleum ether and 
dried to afford (4a-j). 
4.4.1. N-((5-(2,4-Dimethoxyphenyl)-1,3,4-oxadiazole-2-yl)methyl)-4-methoxyaniline (4a) 
        The compound 4a was obtained by the reaction of 3a (1.0 gm, 0.003 mmol) and iodobenzene 
diacetate (1.12 gm, 0.0034 mmol) using the general procedure described for 4(a-j). White solid. FT-
IR (KBr, cm
−1): 3060 (aromatic C-H), 2929 (C-H of CH2), 1680 (C=N), 1464 (C=C), 1375 (C-N), 
1255 (C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 3H, -OCH3), 3.89 (s, 6H, -OCH3), 4.59 (d, 
2H, -CH2), 6.34 (s, 1H, NH), 7.09 (d, 2H, Ar-H), 7.50-7.58 (m, 3H, Ar-H), 7.92 (d, 2H, Ar-H). MS 
(ESI) m/z: 342 (Expected mass: 341). Anal. Calcd. for C18H19N3O4 ( in %): C, 63.33; H, 5.61; N, 
12.31. Found: C, 63.25; H, 5.60; N, 12.25. 
4.4.2. N-((5-(2,3-Dimethoxyphenyl)-1,3,4-oxadiazole-2-yl)methyl)-4-methoxyaniline (4b)  
      The compound 4b was obtained by the reaction of 3b (1.0 gm, 0.003 mmol) and iodobenzene 
diacetate (1.12 gm, 0.0034 mmol) using the general procedure described for 4(a-j). White solid. FT-
IR (KBr, cm
−1): 3070 (aromatic C-H), 2936 (C-H of CH2), 1672 (C=N), 1470 (C=C), 1384 (C-N), 
1243 (C-O).  
1H NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 6H, -OCH3), 3.89 (s, 3H, -OCH3), 4.59 (d, 
2H, -CH2), 6.38 (s, 1H, NH), 7.08 (d, 2H, Ar-H), 7.16-7.20 (d, 2H, Ar-H), 7.85-7.88 (m, 3H, Ar-H). 
MS (ESI) m/z: 342 (Expected mass: 341). Anal. Calcd. for C18H19N3O4 ( in %): C, 63.33; H, 5.61; N, 
12.31. Found: C, 63.22; H, 5.58; N, 12.25.   174
4.4.3. 3-(5-((4-Methoxyphenyl)amino)methyl)-1,3,4-oxadiazole-2-yl)phenol (4c)  
      The compound 4c was obtained by the reaction of 3c (1.0 gm, 0.0033mmol) and iodobenzene 
diacetate (1.29 gm, 0.004 mmol) using the general procedure described for 4(a-j). Brown solid. FT-
IR (KBr, cm
−1): 3515 (OH), 3068 (aromatic C-H), 2930 (C-H of CH2), 1652 (C=N), 1469 (C=C), 
1388 (C-N), 1250 (C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.86 (s, 3H, -OCH3), 4.60 (d, 2H, -CH2), 
5.20 (s, 1H, OH), 6.35 (s, 1H, NH), 6.88 (dd, 2H, Ar-H), 7.22-7.31 (m, 2H, Ar-H), 7.55 (s, 1H, Ar-
H), 7.88 (d, 2H, Ar-H). MS (ESI) m/z: 298 (Expected mass: 297). Anal. Calcd. for C16H15N3O3 (in 
%): C, 64.64; H, 5.09; N, 14.13. Found: C, 64.42; H, 4.89; N, 14.10. 
4.4.4. 4-Methoxy-N-((5-(3-methoxyphenyl)-1,3,4-oxadiazole-2-yl)methyl]aniline (4d)  
       The compound 4d was obtained by the reaction of 3d (1.0 gm, 0.0032 mmol) and iodobenzene 
diacetate  (1.23 gm, 0.0038 mmol) using the general procedure described for 4(a-j). White solid. FT-
IR (KBr, cm
−1): 3060 (aromatic C-H), 2944 (C-H of CH2), 1628 (C=N), 1430 (C=C), 1358 (C-N), 
1247 (C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 6H, -OCH3), 4.58 (d, 2H, -CH2), 6.35 (s, 1H, 
NH), 7.07 (d, 2H, Ar-H), 7.59-7.66 (m, 4H, Ar-H), 7.70 (s, 1H, Ar-H). MS (ESI) m/z: 313 (Expected 
mass: 311). Anal. Calcd. for C17H17N3O3 ( in %): C, 65.88; H, 5.50; N, 13.50. Found: C, 60.50; H, 
4.64; N, 13.55. 
4.4.5. N-((5-(2-Chloro-6-fluorophenyl)-1,3,4-oxadiazole-2-yl)methyl)-4-methoxyaniline (4e)  
        The compound 4e was obtained by the reaction of 3e (1.0 gm, 0.003 mmol) and iodobenzene 
diacetate (1.15 gm, 0.0035 mmol) using the general procedure described for 4(a-j). Pale brown solid. 
FT-IR (KBr, cm
−1): 3072 (aromatic C-H), 2961 (C-H of CH2), 1660 (C=N), 1486 (C=C), 1380 (C-N), 
1236 (C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.89 (s, 3H, -OCH3), 4.59 (d, 2H, -CH2), 6.36 (s, 1H, 
NH), 7.06 (dd, 2H, Ar-H), 7.10-7.13 (t, 1H, Ar-H), 7.40-7.49 (m, 2H, Ar-H), 7.87 (dd, 2H, Ar-H),  
MS (ESI) m/z: 335 (Expected mass: 333). Anal. Calcd. for C16H13ClFN3O2 ( in %): C, 57.58; H, 3.93; 
N, 12.59. Found: C, 57.65; H, 3.99; N, 12.50. 
4.4.6. N-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazole-2-yl)methyl)-4-methoxyaniline (4f)  
      The compound 4f was obtained by the reaction of 3f (1.0 gm, 0.0028 mmol) and iodobenzene 
diacetate (1.1 gm, 0.0031 mmol) using the general procedure described for 4(a-j). White solid. FT-IR 
(KBr, cm
−1): 3070 (aromatic C-H), 2944 (C-H of CH2), 1629 (C=N), 1480 (C=C), 1386 (C-N), 1245 
(C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.88 (s, 3H, -OCH3), 4.60 (d, 2H, -CH2), 6.35 (s, 1H, NH), 
7.01 (dd, 2H, Ar-H), 7.76 (d, 2H, Ar-H), 7.88-7.94 (m, 3H, Ar-H). MS (ESI) m/z: 352 (Expected 
mass: 349). Anal. Calcd. for C15H10Cl2N3O3 ( in %): C, 53.75; H, 3.01; N, 12.54. Found: C, 53.58; H, 
3.05; N, 12.34. 
4.4.7. N-((5-(4-Nitrophenyl)-1,3,4-oxadiazole-2-yl)methyl)-4-methoxyaniline (4g)  
      The compound 4g was obtained by the reaction of 3g (1.0 gm, 0.003 mmol) and iodobenzene 
diacetate  (1.18 gm, 0.0036 mmol) using the general procedure described for 4(a-j). Yellow solid. 
FT-IR (KBr, cm
−1): 3065 (aromatic C-H), 2950 (C-H of CH2), 1634 (C=N), 1481 (C=C), 1380 (C-N), 
1241 (C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 3H, -OCH3), 4.58 (d, 2H, -CH2), 6.34 (s, 1H, 
NH), 7.10-7.18 (m, 4H, Ar-H), 7.76 (d, 2H, Ar-H), 8.10 (d, 2H, Ar-H). MS (ESI) m/z: 327 (Expected 
mass: 326). Anal. Calcd. for C16H14N4O4 ( in %): C, 58.89; H, 4.32; N, 17.17. Found: C, 58.80; H, 
4.30; N, 17.12. 
4.4.8. 4-Methoxy-N-((5-(4-propylphenyl)-1,3,4-oxadiazole-2-yl)methyl)aniline (4h) 
      The compound 4h was obtained by the reaction of 3h (1.0 gm, 0.003 mmol) and iodobenzene 
diacetate (1.15 gm, 0.0035 mmol) using the general procedure described for 4(a-j). White solid. FT-
IR (KBr, cm
−1): 3075 (aromatic C-H), 2950 (C-H of CH2), 1670 (C=N), 1462 (C=C), 1382 (C-N), B. N. Prasanna Kumar et al. / Current Chemistry Letters 2 (2013) 
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1229 (C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 0.92 (t, 3H, CH3), 1.54-1.62 (m, 2H, CH2), 2.49-2.51 
(t, 2H, CH2), 3.87 (s, 3H, -OCH3), 4.59 (d, 2H, -CH2), 6.35 (s, 1H, NH), 7.10 (dd, 2H, Ar-H), 7.42 
(dd, 2H, Ar-H), 7.81 (d, 2H, Ar-H), 7.89-7.92 (m, 2H, Ar-H). MS (ESI) m/z: 324 (Expected mass: 333). 
Anal. Calcd. for C19H21N3O2 ( in %): C, 70.57; H, 6.55; N, 12.99. Found: C, 70.62; H, 6.52; N, 12.95. 
4.4.9. 4-Methoxy-N-((5-(m-tolyl)-1,3,4-oxadiazole-2-yl)methyl)aniline (4i)  
      The compound 4i was obtained by the reaction of 3i (1.0 gm, 0.0033 mmol) and iodobenzene 
diacetate (1.3 gm, 0.004 mmol) using the general procedure described for 4(a-j). White solid. FT-IR 
(KBr, cm
−1): 3063 (aromatic C-H), 2934 (C-H of CH2), 1688 (C=N), 1469 (C=C), 1385 (C-N), 1231 
(C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 2.22 (s, 3H, -CH3), 3.88 (s, 3H, -OCH3), 4.59 (d, 2H, -
CH2), 6.35 (s, 1H, NH), 7.17 (dd, 2H, Ar-H), 7.51 (s, 1H, Ar-H), 7.77-7.82 (m, 4H, Ar-H). MS (ESI) 
m/z: 297 (Expected mass: 295). Anal. Calcd. for C17H17N3O2 ( in %): C, 69.14; H, 5.80; N, 14.23. 
Found: C, 69.10; H, 5.75; N, 14.18. 
4.4.10. N-[{5-(4-Bromophenyl)-1,3,4-oxadiazole-2-yl}methyl]-4-methoxyaniline (4j) 
      The compound 4j was obtained by the reaction of 3j (1.0 gm, 0.0027 mmol) and iodobenzene 
diacetate (1.34 gm, 0.004 mmol) using the general procedure described for 4(a-j). White solid. FT-IR 
(KBr, cm
−1): 3055 (aromatic C-H), 2921 (C-H of CH2), 1682 (C=N), 1465 (C=C), 1380 (C-N), 1240 
(C-O). 
1H NMR (DMSO-d6, 400 MHz) δ: 3.87 (s, 3H, -OCH3), 4.60 (d, 2H, -CH2), 6.34 (s, 1H, NH), 
7.07 (d, 2H, Ar-H), 7.40 (d, 2H, Ar-H), 7.77 (d, 2H, Ar-H), 7.95 (d, 2H, Ar-H). MS (ESI) m/z: 362 
(Expected mass: 360). Anal. Calcd. for C16H14BrN3O2 (in %): C, 53.55; H, 3.92; N, 11.67. Found: C, 
53.23; H, 3.81; N, 11.7.   
4.5. Antibacterial activity 
      Antibacterial  activity  of  the  newly  synthesized  compounds  was  determined  in  DMF  by  disc 
diffusion method on nutrient agar medium
18 by using
 Gram-positive bacteria (Bacillus subtilis and 
Staphylococcus aureus) and Gram-negative bacteria (Xanthomonas campestris and Escherichia coli). 
In each Petri plate the sterile media (Nutrient Agar Medium, 15 mL) was uniformly smeared with 
cultures of both bacteria. Sterile discs of 10 mm diameter (Hi-Media) was placed in the Petri plates, 
to which 50 µL (1 mg/ml i.e., 50 µg/disc) of the new compounds were added. This included 50 µL of 
DMF as negative, bacteriomycin and gentamycin as positive control. The plates were incubated at 37 
± 2 ºC for 24 h and the zone of inhibition was determined.  
4.6. Antifungal activity 
       The synthesized compounds were screened for the antifungal activity in DMF by poisoned food 
technique
19 against Fusarium oxysporum. Prepare Potato Dextrose Agar (PDA) media and about 15 
mL of PDA was poured into each Petri plate and allowed to solidify. 5 mm disc of seven days old 
culture of the test fungi was placed at the center of the Petri plate and incubated at 26 °C for 7 days. 
After incubation the percentage inhibition was measured and three replicates were maintained for 
each treatment. Nystatin was used as standard. All the synthesized compounds were tested (at the 
dosage  of  500  µL  of  the  new  compounds/petriplate,  where  concentration  was  0.1  mg/mL)  by 
poisoned food technique.  
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